JP2024528660A5 - - Google Patents
Info
- Publication number
- JP2024528660A5 JP2024528660A5 JP2024503389A JP2024503389A JP2024528660A5 JP 2024528660 A5 JP2024528660 A5 JP 2024528660A5 JP 2024503389 A JP2024503389 A JP 2024503389A JP 2024503389 A JP2024503389 A JP 2024503389A JP 2024528660 A5 JP2024528660 A5 JP 2024528660A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- domain
- binding
- polypeptide
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163224350P | 2021-07-21 | 2021-07-21 | |
| US63/224,350 | 2021-07-21 | ||
| PCT/US2022/073970 WO2023004368A1 (en) | 2021-07-21 | 2022-07-20 | Linker polypeptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024528660A JP2024528660A (ja) | 2024-07-30 |
| JP2024528660A5 true JP2024528660A5 (https=) | 2025-07-29 |
Family
ID=82939808
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024503389A Pending JP2024528660A (ja) | 2021-07-21 | 2022-07-20 | リンカーポリペプチド |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240417437A1 (https=) |
| EP (1) | EP4373847A1 (https=) |
| JP (1) | JP2024528660A (https=) |
| KR (1) | KR20240070507A (https=) |
| CN (2) | CN119462956A (https=) |
| AU (1) | AU2022314797A1 (https=) |
| CA (1) | CA3226100A1 (https=) |
| IL (1) | IL310137A (https=) |
| MX (1) | MX2024000867A (https=) |
| WO (1) | WO2023004368A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021016599A1 (en) * | 2019-07-25 | 2021-01-28 | Trutino Biosciences Inc | Il-2 cytokine prodrugs comprising a cleavable linker |
| WO2025135700A1 (ko) * | 2023-12-21 | 2025-06-26 | 포항공과대학교 산학협력단 | 지속형 인슐린 유전자 컨스트럭트 및 이의 용도 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| US7018809B1 (en) | 1991-09-19 | 2006-03-28 | Genentech, Inc. | Expression of functional antibody fragments |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
| US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| ES2248127T3 (es) | 1999-10-04 | 2006-03-16 | Medicago Inc. | Metodo para regular la transcripcion de genes foraneos en presencia de nigtrogeno. |
| CN105722860A (zh) * | 2013-09-24 | 2016-06-29 | 梅迪塞纳医疗股份有限公司 | 白介素-2融合蛋白及其应用 |
| AU2019271148B9 (en) * | 2018-05-14 | 2025-05-29 | Werewolf Therapeutics, Inc. | Activatable interleukin-2 polypeptides and methods of use thereof |
| AU2019288484B2 (en) * | 2018-06-22 | 2024-06-20 | Cugene Inc. | Cytokine-based bioactivatable drugs and methods of uses thereof |
| EP3897719A4 (en) * | 2018-12-21 | 2022-11-02 | Zhejiang Shimai Pharmaceutical Co., Ltd. | Protease cleavable bispecific antibodies and uses thereof |
| WO2021016599A1 (en) * | 2019-07-25 | 2021-01-28 | Trutino Biosciences Inc | Il-2 cytokine prodrugs comprising a cleavable linker |
-
2022
- 2022-07-20 CA CA3226100A patent/CA3226100A1/en active Pending
- 2022-07-20 AU AU2022314797A patent/AU2022314797A1/en active Pending
- 2022-07-20 IL IL310137A patent/IL310137A/en unknown
- 2022-07-20 JP JP2024503389A patent/JP2024528660A/ja active Pending
- 2022-07-20 CN CN202410887062.2A patent/CN119462956A/zh active Pending
- 2022-07-20 CN CN202280063746.XA patent/CN118556074A/zh active Pending
- 2022-07-20 WO PCT/US2022/073970 patent/WO2023004368A1/en not_active Ceased
- 2022-07-20 EP EP22755378.1A patent/EP4373847A1/en active Pending
- 2022-07-20 MX MX2024000867A patent/MX2024000867A/es unknown
- 2022-07-20 KR KR1020247005627A patent/KR20240070507A/ko active Pending
-
2024
- 2024-01-18 US US18/416,736 patent/US20240417437A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023511074A5 (https=) | ||
| JP2024528660A5 (https=) | ||
| JP2019513014A5 (https=) | ||
| JP7450684B2 (ja) | 制約されたｃｄ３結合を有する多重特異性ポリペプチド構築物およびそれを使用する方法 | |
| JP2021087429A5 (https=) | ||
| US20210355219A1 (en) | Conditionally activated target-binding molecules | |
| US20200040075A1 (en) | V-c-fc-v-c antibody | |
| JP2020188772A (ja) | プロテアーゼにより活性化可能な二重特異性タンパク質 | |
| JP2023526428A5 (https=) | ||
| EP3934761A1 (en) | Conditionally activated binding proteins containing fc regions and moieties targeting tumor antigens | |
| WO2015063187A1 (en) | Multivalent antigen-binding proteins | |
| AU2006252078B2 (en) | Recombinant Triplex Scaffold-based Polypeptides | |
| JP2020534811A (ja) | Ｆｃ領域を含有する条件的に活性化された結合部分 | |
| JP2023541771A5 (https=) | ||
| TW202235438A (zh) | 能夠調節配體結合活性的配體結合分子 | |
| US20240043489A1 (en) | Cytokine Prodrugs Comprising a Cleavable Linker | |
| US20240417437A1 (en) | Linker Polypeptides | |
| CN116745316A (zh) | 具有人血清白蛋白结构域的受限条件激活结合蛋白构建体 | |
| CN116419925A (zh) | 受限的条件激活的结合蛋白 | |
| US8961971B2 (en) | Bispecific T-cell activator antibody | |
| EP4259663A1 (en) | Conditionally bispecific binding proteins | |
| JP2024500189A5 (https=) | ||
| CN121002071A (zh) | IL-12 Fc融合蛋白 | |
| JP2025511190A5 (https=) | ||
| JP2024531338A (ja) | 活性化可能インターフェロンポリペプチド及びその使用方法 |